NEW YORK: The GCI Group has promoted Michael Roth to SVP,
healthcare practice. Previously, Roth was in charge of the Forest
Laboratories account, where he managed PR for Forest's antidepressant
drug Celexa, as well as Forest's interactive work. Roth's PR background
includes experience across a wide range of medical fields, including
sleep disorders, central nervous system diseases, chronic pain
management, cardiology, ophthalmology, oncology, and antiherpetics.